| 2000
McCoy Award Recipient
Nicholas A. Peppas
Professor Biomedical Engineering
Professor Nicholas
A. Peppas, Showalter
Distinguished Professor
of Biomedical Engineering,
was presented the prestigious
Herbert Newby McCoy Award
during the University Honors
Convocation held April
14, 2000, for contributions
to science for his research
on therapeutic formulations
for protein and drug delivery.
Professor Nicholas A. Peppas
is the Showalter Distinguished
Professor of Chemical and
Biomedical Engineering
of Purdue University. He
has been at Purdue since
1976 and holds joint appointments
in the School of Chemical
Engineering and the new
Department of Biomedical
Engineering, which he helped
found. In addition, he
is the Director of the
National Science Foundation
Program on Therapeutic
and Diagnostic Devices,
an innovative educational,
training and research program
formed wit h the support
of NSF in 1999 and spanning
seven different schools
and departments in the
Lafayette and Indianapolis
campus.
Peppas was educated in chemical
engineering at the National
Technical University of
Athens, Greece (Dipl.Eng.,
1971) and at the Massachusetts
Institute of Technology
(Sc.D., 1973). In addition
to his Purdue appointment,
he has served as a Visiting
Professor at the Universities
of Geneva (Switzerland),
Paris XIII (France), Parma
(Italy), Naples (Italy),
Pavia (Italy), Hoshi (Tokyo,
Japan), Hebrew (Jerusalem,
Israel) and the California
Institute of Technology.
In 2001, he will be a Visiting
Professor at the Free University
of Berlin (Germany), and
at the University of Santiago
de Compostela and the Complutense
University of Madrid (Spain).
His research contributions
cover a wide range of fundamental
studies in macromolecular
science, drug delivery,
biomedical polymers, mass
transfer, polymerization
kinetics and biomedical
engineering. His group
has contributed to the
dynamics of macromolecular
chains in dilute and semi-dilute
solutions, as well as to
the behavior of complex
macromolecular chains in
contact with biological
surfaces. He is internationally
known for his work on the
preparation, characterization
and evaluation of the behavior
of a class of crosslinked
polymers known as hydrogels,
which have been used as
biocompatible materials
and as carriers in controlled
delivery of drugs, peptides
and proteins.
Peppas' work does not only
address the fundamentals
of his field but has also
found a wide range of applications
in the biomedical field.
His group pioneered the
use of hydrogels in drug
delivery applications,
including epidermal bioadhesive
systems and systems for
the release of theophylline,
proxyphylline, diltiazem,
and oxprenolol. Upon study
of the critical behavior
of intelligent polymers,
Peppas and his group were
the first to employ such
pH-sensitive and temperature-sensitive
systems for modulated release
of streptokinase and other
fibrinolytic enzymes. His
group has also developed
novel transmucosal controlled
release devices. More recently,
his group has announced
new inventions of oral
insulin delivery systems
and new biomaterials. Peppas'
group has also invented
new materials for hard,
oxygen-permeable contact
lenses, and for reconstruction
of vocal cords.
In recognition of his research
accomplishments he has
received honorary doctorates
from the University of
Ghent (Belgium, 1999),
the University of Parma
(Italy, 1999), and the
University of Athens (Greece,
2000).
Peppas is the co-author or
coeditor of 25 books and
volumes, and the author
of 650 publications, 280
proceedings papers and
preprints, 200 abstracts
and 10 patents. He is one
of the most cited scientists
in the world according
to the recent ISI survey
of most cited authors for
the period 1981- June 1997.
Since 1982, he has been
the editor of the premier
Journal in his field, Biomaterials.
Since 1998 he has been
one of the editors of Advances
in Chemical Engineering.
Peppas has been recognized
by more than 60 awards
including the 2000 General
Electric Senior Research
Award of ASEE recognizing
the best engineering researcher
of the USA,; the 1999 Research
Achievement Award in Pharmaceutical
Technology of the American
Association of Pharmaceutical
Scientists,; the 1995 APV-International
Pharmaceutical Technology
Medal,; the 1994 Food,
Pharmaceutical and Bioengineering
Award of the American Institute
of Chemical Engineers,;
the 1992 Clemson Award
for Basic Research of the
Society for Biomaterials,;
the 1992 George Westinghouse
Award of ASEE,; the 1991
Founders Award for Outstanding
Research from the Controlled
Release Society,; the 1988
Curtis McGraw Award of
ASEE for best ngineering
research under the age
of 40,; and the 1984 Materials
Engineering and Sciences
Award of the American Institute
of Chemical Engineers.
Peppas has been elected a
Founding Fellow of the
American Institute of Medical
and Biological Engineering
(1993), a Fellow of the
American Association of
the Advancement of Science
(2000), a Fellow of the
American Physical Society
(1997), a Fellow of the
American Institute of Chemical
Engineers (1997), a Fellow
of the Society for Biomaterials
(1994), a Fellow of the
American Association of
Pharmaceutical Scientists
(1993) and an Honorary
Member of the Italian Society
of Medicine and Natural
Sciences (1996). In 1991
he was named a Polymer
Pioneer by Polymer News.
He has supervised the theses
of 45 Ph.D. students, including
20 current professors in
other Universities, and
another 70 students, postdoctoral
fellows and visiting scientists.
Abstract of talk
Novel complexation copolymer
networks of poly(methacrylic
acid) grafted with poly(ethylene
glycol) have been shown
to be excellent carriers
for proteins due to their
pH-sensitive swelling behavior
as a result of the formation
of reversible interpolymer
complexes stabilized by
hydrogen bonding between
the carboxylic acid protons
and the etheric groups
on the grafted chains.
Additionally, the presence
of the PEG grafts stabilizes
entrapped peptides and
proteins. Because of the
complexation phenomena
in these networks, the
characteristic mesh size
in these gels is an order
of magnitude greater in
the uncomplexed state than
in the complexed state.
Because of their oscillatory
swelling behavior, these
gels can be used as oral
carriers for insulin and
calcitonin where the release
of the bioactive agent
in the intestine is preferable.
Upon oral administration
of insulin loaded gels,
the blood glucose levels
in rats were significantly
reduced due to release
of insulin in the upper
small intestine. Recent
studies with nanoparticles
of these gels in contact
with CaCo-2 cells indicate
lack of cytotoxicity and
improved permeability by
paracellular transport.
Micropatterning and molecular
imprinting using such intelligent
biopolymers are powerful
techniques for the preparation
of films with highly specific
molecular recognition capabilities.
The importance of these
techniques is related to
the characteristics of
molecular recognition.
Recognition is provided
by various groups that
govern the specificity
and affinity of biological
molecules for other compounds.
Molecularly imprinted polymers
(MIP's) have the same type
of recognition as spatially
distinct functional groups,
i.e. synthetic counterparts
to biological molecules.
MIP's possess "cavities"
with high specificity and
binding affinity for the
template molecule, recognized
by non-covalent, covalent
or metal coordination interactions.
A high amount of cross-linking
provides the required rigidity
of the structure. We have
developed several approaches
for the preparation of
MIPs. Most of our studies
have been with the non-covalent
approach, where the interaction
between monomers and template
is achieved by various
non-covalent interactions
such as hydrogen bonding,
ionic or electrostatic
interactions. The clear
advantage of this technique
is the ease of preparation
of the polymers. The monomers
and template are simply
mixed together and allowed
to interact based on the
idea of "self-assembly".
The disadvantages of this
approach include the equilibrium-governed
nature of the interactions
and the possibility of
the creation of unfavorable
binding sites.
The idea of patterning the
properties and surfaces
at the molecular level
is of extreme interest
for controlling the adsorption
of proteins and the attachment
of cells for applications
in biosensors and tissue
engineering. Micropatterns
aid the adsorption process
tremendously by allowing
for very selective adhesion.
Research
Peppas joined Purdue in
1976 and established an
internationally recognized
program in polymers, biomaterials
and drug delivery. His
contributions have been
in polymers, biomedical
engineering, biomaterials,
drug delivery, mass transfer,
kinetics and reaction engineering.
His polymer research has
examined fundamental aspects
of the thermodynamics of
polymer networks in contact
with solvents, the conformational
changes of networks under
load or in the presence
of a solvent, the anomalous
transport of liquids in
glassy polymers, and the
kinetics of fast UV-polymerization
reactions. This work easily
explains most aspects of
gaseous diffusion.
In the field of polymer science,
Peppas investigated the
effects of polymer structural
characteristics on the
diffusion coefficient and
diffusion behavior of small
and large molecules, concentrating
on the diffusion of liquid
penetrants and macromolecules
through glassy and rubbery
polymers in the presence
or absence of macromolecular
relaxations. He developed
exact molecular and approximate
phenomenological theories
for describing such systems.
He developed new molecular
theories that account for
the effect of the macromolecular
structure of polymers on
its solute diffusion coefficient.
For example, Peppas introduced
two theories that can predict
the dependence on the number
average molecular weight
between crosslinks, the
hydrodynamic radius of
the solute, and the degree
of swelling for highly
and moderately swollen
nonporous membranes. Along
with Prof. Caruthers, he
developed necessary and
sufficient conditions for
Fickian and non-Fickian
diffusion of a solute through
glassy swellable polymers.
Their continuum thermodynamic
theory to describe anomalous
transport in glassy polymers
is a classic paper in the
literature, and the experimental
verification of this model
has led to its wide applicability
in the field.
In addition, Peppas has investigated
polymer-polymer interdiffusion
and provided important
physical interpretation
of adhesion and healing
phenomena. This work has
yielded models and experimental
studies of systems important
in controlled-release applications.
He investigated gaseous
diffusion through rubbery
and semicrystalline polymers
and through glassy polymers
where gaseous solubility
in the polymer is progressively
altered by changing the
structure of the glassy
copolymer. His fundamental
studies illuminated the
nature of hydrogen bonding
in complexation hydrogels,
crystallization of polymers,
rubber elasticity of networks,
structure of crosslinked
polystyrene, structure
of polymerldiluent systems,
and block copolymers. He
performed significant work
on the polymerization kinetics
of acrylates and methacrylates,
especially multifunctional
monomers used in producing
networks. Peppas has studied
the preparation and properties
of highly crosslinked polymers,
which can be used in such
high-tech applications
as coatings, films, optical
fibers, compact disks,
and lenses. He developed
fundamental descriptions
for the propagation and
termination rate constants
of multifunctional polymerization/crosslinking
reactions.
Peppas' research accomplishments
in bioengineering include
investigation of the surface
properties of hydrogels
in relation to medical
applications and applied
such systems to the development
of materials for articular
cartilage, vocal cords,
contact lenses, artificial
kidney membranes, and artificial
organs in general. Peppas
performed pioneering work
in developing biomedical
surfaces for a portable
artificial kidney and for
systems to treat thrombotic
effects defects through
the use of streptokinase
form from fibrinolytic
enzymeimmobilized microparticles.
He showed that diffusional
effects play an important
role in protein adsorption
on polymeric surfaces for
biomedical applications.
He developed, with his
research group, new biomaterials
based on methacrylates,
acrylates, polyvinyl alcohol)
and polyethylene glycol).
The research group has
shown that the pH-sensitivity
of many of these systems
can be used to develop
intelligent biomedical
devices and biosensors.
Finally, he contributed
to our understanding of
biomedical transport and
interfacial phenomena,
from the study of arteriosclerosis
to solute transport in
mucus and transport in
bioadhesion.
Peppas is also a leading
authority on therapeutic
formulations for protein
and drug delivery. He is
internationally known for
his work on preparing,
characterizing, and evaluating
the behavior of compatible,
crosslinked polymers known
as hydrogels, which have
been used as biocompatible
materials and in controlled
release devices, especially
in controlled delivery
of drugs, peptides, and
proteins, development of
novel biomaterials, biomedical
transport phenomena, and
biointerfacial problems.
In drug delivery, Peppas
originated and is the leading
proponent of the use of
hydrophilic polymers and
hydrogels for the controlled
delivery of drugs, peptides,
and proteins. He developed
the new class of "swelling-controlled
release systems,"
which exhibit an unexpected
time-dependent (zero-order)
release due to coupling
of diffusional and relaxational
mechanisms. Peppas and
his students were the first
to propose and solve complex
transport equations incorporating
the viscoelastic behavior
of the polymer and its
relaxational behavior during
swelling and drug release.
He also introduced two
dimensionless numbers,
the Swelling Interface
number (Sw) and the Swelling
Area number (Sa), used
by researchers in the discipline.
He proposed the now well-known
exponential time dependence
of the quantity of drug
released, which has become
a most desirable equation
for the analysis of non-Fickian
drug delivery.
Peppas also developed and
tested, with his students,
systems for release of
vasodilators such as theophylline
and proxyphilline, beta-Mockers
blockers such as oxprenolol
and anti-inflammatory agents
such as metronidasole.
He has made seminal contributions
to the understanding of
release from pH-sensitive
and temperature-sensitive
swelling systems. In collaboration
with colleagues he described
the characteristics of
pH-sensitive delivery,
analyzed the oscillatory
behavior using Bolzman
superposition analysis,
showed the influence of
ionic strength and buffer
composition on controlled
release, and developed
new delivery systems. Of
particular interest is
the work on insulin delivery
using pH- and temperature-sensitive
release systems. He and
his research group made
exceptional contributions
to the development of novel
mucoadhesive systems for
targeted delivery.
|